Missouri City, TX, United States of America

Carrie Brookner

This inventor holds 1 USPTO granted patent. Top assignee: Lifespex, Inc.. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Carrie Brookner

Introduction

Carrie Brookner is a notable inventor based in Missouri City, TX (US). She has made significant contributions to the field of fluorescence spectroscopy, particularly in the detection of tissue abnormalities. Her innovative approach has the potential to enhance diagnostic capabilities in medical settings.

Latest Patents

Carrie Brookner holds a patent for her invention titled "Acetic acid as a signal enhancing contrast agent in fluorescence spectroscopy." This method utilizes acetic acid to improve the signal response during fluorescence spectroscopy of both normal and neoplastic tissue, especially epithelium. The invention outlines a process for detecting tissue abnormalities in diagnostic samples by comparing fluorescence intensity spectra before and after the application of acetic acid.

Career Highlights

Carrie is currently associated with Lifespex, Inc., where she continues to develop her innovative ideas. Her work focuses on enhancing diagnostic techniques that can lead to better patient outcomes. With her expertise, she has contributed to advancing the understanding of tissue analysis.

Collaborations

Throughout her career, Carrie has collaborated with esteemed colleagues such as Rebecca Rae Richards-Kortum and Anant Agrawal. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Carrie Brookner's contributions to the field of fluorescence spectroscopy exemplify the impact of innovative thinking in medical diagnostics. Her patent and ongoing work at Lifespex, Inc. highlight her commitment to improving healthcare through technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…